Enanta Pharmaceuticals, Inc. (ENTA)
13.60
-0.20
(-1.45%)
USD |
NASDAQ |
Aug 28, 16:00
13.58
-0.02
(-0.11%)
After-Hours: 20:00
Enanta Pharmaceuticals Shareholders Equity (Quarterly) : 101.07M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 101.07M |
| March 31, 2026 | 116.59M |
| December 31, 2025 | 126.59M |
| September 30, 2025 | 64.72M |
| June 30, 2025 | 79.28M |
| March 31, 2025 | 93.54M |
| December 31, 2024 | 111.82M |
| September 30, 2024 | 128.81M |
| June 30, 2024 | 148.92M |
| March 31, 2024 | 166.11M |
| December 31, 2023 | 191.88M |
| September 30, 2023 | 216.74M |
| June 30, 2023 | 237.82M |
| March 31, 2023 | 269.38M |
| December 31, 2022 | 300.84M |
| September 30, 2022 | 321.33M |
| June 30, 2022 | 338.02M |
| March 31, 2022 | 358.58M |
| December 31, 2021 | 384.38M |
| September 30, 2021 | 399.43M |
| June 30, 2021 | 417.85M |
| March 31, 2021 | 436.03M |
| December 31, 2020 | 452.00M |
| September 30, 2020 | 455.58M |
| June 30, 2020 | 480.56M |
| Date | Value |
|---|---|
| March 31, 2020 | 485.99M |
| December 31, 2019 | 482.29M |
| September 30, 2019 | 462.49M |
| June 30, 2019 | 448.10M |
| March 31, 2019 | 436.21M |
| December 31, 2018 | 426.84M |
| September 30, 2018 | 393.68M |
| June 30, 2018 | 360.90M |
| March 31, 2018 | 333.40M |
| December 31, 2017 | 317.58M |
| September 30, 2017 | 301.68M |
| June 30, 2017 | 260.87M |
| March 31, 2017 | 266.01M |
| December 31, 2016 | 268.17M |
| September 30, 2016 | 269.94M |
| June 30, 2016 | 269.01M |
| March 31, 2016 | 266.42M |
| December 31, 2015 | 264.28M |
| September 30, 2015 | 236.16M |
| June 30, 2015 | 228.28M |
| March 31, 2015 | 224.22M |
| December 31, 2014 | 193.71M |
| September 30, 2014 | 148.86M |
| June 30, 2014 | 152.95M |
| March 31, 2014 | 101.72M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 323.86M |
| AbbVie, Inc. | -5.935B |
| Coherus Oncology, Inc. | 60.84M |
| BridgeBio Pharma, Inc. | -2.515B |
| RenovoRx, Inc. | 8.979M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 296.87M |
| Total Liabilities (Quarterly) | 195.80M |
| Debt to Equity Ratio | 1.801 |
| Current Ratio | 3.759 |
| Net Debt Paydown Yield | 1.61% |